24 "inflammatory bowel diseases" clinical trials found.
-
Treat-to-Target of Endoscopic Remission in Patients with IBD in Symptomatic Remission
The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to ... -
NYU Langone IBD Biorepository
We are building a biorepository of samples from patients who have Inflammatory Bowel Diseases and controls. Samples will include blood, stool, and mucosal biopsy samples. -
Screening Assessment of Overlap Spondyloarthritis in Patients with Inflammatory Bowel Disease
Despite the known prevalence of SpA in patients with IBD, a formalized screening and disease activity monitoring strategy is not routine standard of care. This ... -
Sarcopenia as a Risk Factor for Adverse Postoperative Outcomes in IBD
We will conduct a prospective cohort study of 120 patients at NYU Langone. Patients who have a biopsy confirmed diagnosis of IBD, who are = 18 ... -
Corevitas Inflammatory Bowel Disease (IBD) Registry
The primary objective for this registry is to prospectively study the natural history of IBD, the prevalence and incidence of comorbidities, and targeted adverse events ... -
Role of the oral cavity in inflammatory bowel disease
The purpose of this investigation is to create a study bank of clinical data, peripheral blood, oral and gut microbiomes, and mucosal pinch biopsy specimens ... -
A Phase 3 Randomized Double-Blind Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn s Disease
This trial is testing an experimental drug tulisokibart (MK-7240) in people with moderately to severely active Crohn’s disease (CD). This trial will compare tulisokibart ... -
Helmsley 3.0: Abbreviated MRE
The main reason for this research study is to compare a shortened, research MRI of the bowel, or MR enterography (MRE) with that of the ... -
Observational Study of Vedolizumab and Ustekinumab in Crohn's Disease Patients in Canada and the US
This is a real-world, multicenter, retrospective, observational, chart review study evaluating the outcomes of treatment with Vedolizumab (VDZ) and Ustekinumab (UST) in patients with Crohn ... -
Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn s disease: The OPTIMIZE Trial
This is a randomized, controlled, multicenter, open-label study. All eligible subjects will be randomly assigned in a 1:1 ratio to receive either IFX monotherapy ...